Delphic Diagnostics

About:

Delphic Diagnostics is a laboratory company that provides pharmacology, pharmacogenetic, and virology services to pharmaceutical companies.

Website: http://www.delphicdiagnostics.com

Top Investors: MMC Ventures

Description:

Delphic Diagnostics is a laboratory company that provides pharmacology, pharmacogenetic, and virology services to pharmaceutical companies, clinical research organizations, and the healthcare sector. It offers bio-equivalence studies, pharmacokinetic studies, validated methods, drug/drug interaction studies, dose escalating studies, clinical interpretation/bioinformatics, DMET panel, genotyping, nucleic acid extraction, validated methods, customized pharmacogenetics and resequencing, viral resistance, qualitative and quantitative viral load, flow cytometry, tropism, project management, and data and logistics services. The company also offers data management, sample logistics, therapeutic drug monitoring, viral resistance testing, immunology, pharmacology, blood brone virus screening, dried blood spots, oral fluids, BBV assays, and clinical trials services. Delphic Diagnostics Limited was incorporated in 2001 and is based in London, United Kingdom with laboratories in Liverpool and Kent, United Kingdom.

Total Funding Amount:

675000 EUR

Headquarters Location:

London, England, United Kingdom

Founded Date:

2001-01-01

Contact Email:

troy.delphia.techsupport(AT)delphi.com

Founders:

Number of Employees:

11-50

Last Funding Date:

2005-11-01

IPO Status:

Private

Industries:

© 2025 bioDAO.ai